Engineers Gate Manager LP - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.

Quarter-by-quarter ownership
Engineers Gate Manager LP ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$475,858
-5.0%
95,746
-5.5%
0.02%
-14.3%
Q1 2023$500,743
-41.1%
101,365
-25.0%
0.02%
-58.8%
Q4 2022$849,647
+63.4%
135,079
+180.6%
0.05%
+59.4%
Q3 2022$520,000
+73.3%
48,144
+139.5%
0.03%
+146.2%
Q4 2021$300,000
-47.6%
20,105
-8.5%
0.01%
-64.9%
Q2 2021$573,000
+65.1%
21,980
+123.6%
0.04%
+117.6%
Q1 2021$347,0009,8300.02%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders